STOCK TITAN

Fractyl Health (GUTS) director Marc Elia receives 22,500-share stock option grant

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

FRACTYL HEALTH, INC. director Marc Elia received a stock option grant covering 22,500 shares of common stock as compensation for board service. The option has an exercise price of $0.7318 per share and expires on June 9, 2036.

The award will vest and become exercisable in a single installment on the earlier of the next annual stockholder meeting or the first anniversary of the grant, subject to Elia’s continued service as a non-employee director. After this grant, he holds 22,500 stock options directly.

Positive

  • None.

Negative

  • None.
Insider Elia Marc
Role Director
Type Security Shares Price Value
Grant/Award Stock Option 22,500 $0.00 --
Holdings After Transaction: Stock Option — 22,500 shares (Direct)
Footnotes (1)
  1. [object Object]
Option grant size 22,500 shares Stock option covering common stock
Exercise price $0.7318 per share Stock option exercise price
Expiration date June 9, 2036 Option expiration
Shares underlying option 22,500 shares Underlying common stock
Post-grant option holdings 22,500 options Total stock options following transaction
Stock Option financial
"The stock option was awarded as compensation for the Reporting Person's service"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
non-employee director compensation policy financial
"pursuant to the Issuer's non-employee director compensation policy"
vest and become exercisable financial
"The stock option will vest and become exercisable in a single installment"
annual meeting of stockholders financial
"on the earlier of (i) the date of the next annual meeting of stockholders"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did FRACTYL HEALTH (GUTS) disclose for Marc Elia?

FRACTYL HEALTH disclosed that director Marc Elia received a stock option grant for 22,500 shares. The award is compensation for his board service and gives him the right to buy common stock at a fixed exercise price if it vests and he chooses to exercise.

How many FRACTYL HEALTH (GUTS) shares are covered by Marc Elia’s new option?

Marc Elia’s new stock option covers 22,500 shares of FRACTYL HEALTH common stock. These options give him potential future ownership if they vest and he exercises them, aligning part of his compensation with the company’s equity performance over time.

What is the exercise price of Marc Elia’s FRACTYL HEALTH (GUTS) stock option?

The stock option granted to Marc Elia has an exercise price of $0.7318 per share. This means he can purchase FRACTYL HEALTH common stock at $0.7318 for each optioned share once the award vests and before the option’s stated expiration date.

When does Marc Elia’s FRACTYL HEALTH (GUTS) stock option vest?

Marc Elia’s stock option vests in a single installment on the earlier of the next annual stockholder meeting or the first anniversary of the grant. Vesting is conditioned on his continued service on FRACTYL HEALTH’s board as a non-employee director through that vesting date.

When does Marc Elia’s FRACTYL HEALTH (GUTS) stock option expire?

The stock option granted to Marc Elia expires on June 9, 2036. He may exercise vested portions any time before that expiration date, subject to the plan’s terms and his continued eligibility under the company’s non-employee director compensation policy.

Is Marc Elia’s FRACTYL HEALTH (GUTS) option grant an open-market purchase or compensation?

Marc Elia’s option grant is compensation, not an open-market purchase. The filing states the stock option was awarded under FRACTYL HEALTH’s non-employee director compensation policy in recognition of his service on the board, with no cash paid per option at grant.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Elia Marc

(Last)(First)(Middle)
3 VAN DE GRAAFF DRIVE
SUITE 200

(Street)
BURLINGTON MASSACHUSETTS 01803

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
FRACTYL HEALTH, INC. [ GUTS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$0.731806/10/2026A22,500 (1)06/09/2036Common Stock22,500$022,500D
Explanation of Responses:
1. The stock option was awarded as compensation for the Reporting Person's service on the Issuer's board of directors pursuant to the Issuer's non-employee director compensation policy. The stock option will vest and become exercisable in a single installment on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the first anniversary of the grant, in each case subject to continued service on the Issuer's board of directors as a non-employee director through the vesting date.
/s/ Harith Rajagopalan, M.D., Ph.D., Attorney-in-fact06/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)